BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 15570601)

  • 1. Glass transition-related changes in molecular mobility below glass transition temperature of freeze-dried formulations, as measured by dielectric spectroscopy and solid state nuclear magnetic resonance.
    Yoshioka S; Aso Y
    J Pharm Sci; 2005 Feb; 94(2):275-87. PubMed ID: 15570601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different molecular motions in lyophilized protein formulations as determined by laboratory and rotating frame spin-lattice relaxation times.
    Yoshioka S; Aso Y; Kojima S
    J Pharm Sci; 2002 Oct; 91(10):2203-10. PubMed ID: 12226847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dependence of the molecular mobility and protein stability of freeze-dried gamma-globulin formulations on the molecular weight of dextran.
    Yoshioka S; Aso Y; Kojima S
    Pharm Res; 1997 Jun; 14(6):736-41. PubMed ID: 9210190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of sugars on the molecular motion of freeze-dried protein formulations reflected by NMR relaxation times.
    Yoshioka S; Forney KM; Aso Y; Pikal MJ
    Pharm Res; 2011 Dec; 28(12):3237-47. PubMed ID: 21706266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mobility of amorphous S-flurbiprofen: a dielectric relaxation spectroscopy approach.
    Rodrigues AC; Viciosa MT; Danède F; Affouard F; Correia NT
    Mol Pharm; 2014 Jan; 11(1):112-30. PubMed ID: 24215236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of the onset of crystallization of amorphous sucrose below the calorimetric glass transition temperature from correlations with mobility.
    Bhugra C; Rambhatla S; Bakri A; Duddu SP; Miller DP; Pikal MJ; Lechuga-Ballesteros D
    J Pharm Sci; 2007 May; 96(5):1258-69. PubMed ID: 17455303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mobility of lyophilized poly(vinylpyrrolidone) and methylcellulose as determined by the laboratory and rotating frame spin-lattice relaxation times of 1H and 13C.
    Yoshioka S; Aso Y; Kojima S
    Chem Pharm Bull (Tokyo); 2003 Nov; 51(11):1289-92. PubMed ID: 14600374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mobility of protein in lyophilized formulations linked to the molecular mobility of polymer excipients, as determined by high resolution 13C solid-state NMR.
    Yoshioka S; Aso Y; Kojima S; Sakurai S; Fujiwara T; Akutsu H
    Pharm Res; 1999 Oct; 16(10):1621-5. PubMed ID: 10554107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temperature- and glass transition temperature-dependence of bimolecular reaction rates in lyophilized formulations described by the Adam-Gibbs-Vogel equation.
    Yoshioka S; Aso Y; Kojima S
    J Pharm Sci; 2004 Apr; 93(4):1062-9. PubMed ID: 14999742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Softening temperature of lyophilized bovine serum albumin and gamma-globulin as measured by spin-spin relaxation time of protein protons.
    Yoshioka S; Aso Y; Kojima S
    J Pharm Sci; 1997 Apr; 86(4):470-4. PubMed ID: 9109051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of excipients on the molecular mobility of lyophilized formulations, as measured by glass transition temperature and NMR relaxation-based critical mobility temperature.
    Yoshioka S; Aso Y; Kojima S
    Pharm Res; 1999 Jan; 16(1):135-40. PubMed ID: 9950292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-relaxation of insulin molecule in lyophilized formulations containing trehalose or dextran as a determinant of chemical reactivity.
    Yoshioka S; Miyazaki T; Aso Y
    Pharm Res; 2006 May; 23(5):961-6. PubMed ID: 16715386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of dynamics in complex lyophilized formulations: I. Comparison of relaxation times measured by isothermal calorimetry with data estimated from the width of the glass transition temperature region.
    Chieng N; Mizuno M; Pikal M
    Eur J Pharm Biopharm; 2013 Oct; 85(2):189-96. PubMed ID: 23608636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of annealing on the stability of amorphous solids: chemical stability of freeze-dried moxalactam.
    Abdul-Fattah AM; Dellerman KM; Bogner RH; Pikal MJ
    J Pharm Sci; 2007 May; 96(5):1237-50. PubMed ID: 17455341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mobility as an effective predictor of the physical stability of amorphous trehalose.
    Bhardwaj SP; Suryanarayanan R
    Mol Pharm; 2012 Nov; 9(11):3209-17. PubMed ID: 23003337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular relaxation behavior and isothermal crystallization above glass transition temperature of amorphous hesperetin.
    Shete G; Khomane KS; Bansal AK
    J Pharm Sci; 2014 Jan; 103(1):167-78. PubMed ID: 24186540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does Brillouin light scattering probe the primary glass transition process at temperatures well above glass transition?
    Voudouris P; Gomopoulos N; Le Grand A; Hadjichristidis N; Floudas G; Ediger MD; Fytas G
    J Chem Phys; 2010 Feb; 132(7):074906. PubMed ID: 20170250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictions of onset of crystallization from experimental relaxation times I-correlation of molecular mobility from temperatures above the glass transition to temperatures below the glass transition.
    Bhugra C; Shmeis R; Krill SL; Pikal MJ
    Pharm Res; 2006 Oct; 23(10):2277-90. PubMed ID: 16933094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of dextran on thermal properties, product quality attributes, and monoclonal antibody stability in freeze-dried formulations.
    Haeuser C; Goldbach P; Huwyler J; Friess W; Allmendinger A
    Eur J Pharm Biopharm; 2020 Feb; 147():45-56. PubMed ID: 31866444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dielectric study of the molecular mobility and the isothermal crystallization kinetics of an amorphous pharmaceutical drug substance.
    Alie J; Menegotto J; Cardon P; Duplaa H; Caron A; Lacabanne C; Bauer M
    J Pharm Sci; 2004 Jan; 93(1):218-33. PubMed ID: 14648651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.